Abstract
Both intracerebral and subarachnoid hemorrhages are associated with high mortality and most survivors are burdened with severe disability. Currently, there is no approved treatment for intracerebral hemorrhage and surgical evacuation was not proven beneficial. Regarding subarachnoid hemorrhage, existing therapies need substantial improvement. Detailed pathophysiologic mechanisms need to be understood in order to develop novel therapeutic strategies. Hemorrhagic stroke models can help achieve both these goals and answer those questions that cannot be addressed in the clinical setting. There are several animal models of intracerebral and subarachnoid hemorrhage, each mimicking fairly reliably different aspects of the condition studied. The similarities and differences among the existing rodent models, model modifications, and some aspects concerning the choice of relevant model are discussed.
Keywords: Stroke, hemorrhage, therapy, rat, mouse, model, magnetic resonance imaging
Current Pharmaceutical Design
Title: Rodent Models of Hemorrhagic Stroke
Volume: 14 Issue: 4
Author(s): D. Strbian, A. Durukan and T. Tatlisumak
Affiliation:
Keywords: Stroke, hemorrhage, therapy, rat, mouse, model, magnetic resonance imaging
Abstract: Both intracerebral and subarachnoid hemorrhages are associated with high mortality and most survivors are burdened with severe disability. Currently, there is no approved treatment for intracerebral hemorrhage and surgical evacuation was not proven beneficial. Regarding subarachnoid hemorrhage, existing therapies need substantial improvement. Detailed pathophysiologic mechanisms need to be understood in order to develop novel therapeutic strategies. Hemorrhagic stroke models can help achieve both these goals and answer those questions that cannot be addressed in the clinical setting. There are several animal models of intracerebral and subarachnoid hemorrhage, each mimicking fairly reliably different aspects of the condition studied. The similarities and differences among the existing rodent models, model modifications, and some aspects concerning the choice of relevant model are discussed.
Export Options
About this article
Cite this article as:
Strbian D., Durukan A. and Tatlisumak T., Rodent Models of Hemorrhagic Stroke, Current Pharmaceutical Design 2008; 14 (4) . https://dx.doi.org/10.2174/138161208783497723
DOI https://dx.doi.org/10.2174/138161208783497723 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preeclampsia Emerging as a Novel Risk Factor for Cardiovascular Disease in the Offspring
Current Pediatric Reviews Pigment Epithelium-derived Factor (PEDF) and Cardiometabolic Disorders
Current Pharmaceutical Design Synthesis of Novel Benzoquinones with Anti-Inflammatory Activity
Letters in Drug Design & Discovery Experimental Methods and Transport Models for Drug Delivery Across the Blood-Brain Barrier
Current Pharmaceutical Biotechnology Treatment of Acute Hypercalcemia
Medicinal Chemistry Intracranial Aneurysms in Sickle Cell Disease
Current Neurovascular Research An Expanding Role of Biomarkers in Pulmonary Arterial Hypertension
Current Pharmaceutical Biotechnology REM Sleep Behavior Disorder and Narcolepsy
CNS & Neurological Disorders - Drug Targets Estrogen Deprivation and Myocardial Infarction: Role of Aerobic Exercise Training, Inflammation and Metabolomics
Current Cardiology Reviews A Systematic Review of First Trimester Biochemical and Molecular Predictive Tests for Preeclampsia
Current Hypertension Reviews A Review of Recent Patents on the ASICs as a Key Drug Target
Recent Patents on Biotechnology Diagnosis of Surgically-Treatable Forms of Primary Aldosteronism
Current Hypertension Reviews Poly (D,L-Lactide-co-Glycolide) Nanoparticles Loaded with Cerebrolysin Display Neuroprotective Activity in a Rat Model of Concussive Head Injury
CNS & Neurological Disorders - Drug Targets Dehydroepiandrosterone (DHEA): A Steroid with Multiple Effects. Is there Any Possible Option in the Treatment of Critical illness?
Current Medicinal Chemistry Tyrosine Kinase Inhibitors – A Review on Pharmacology, Metabolism and Side Effects
Current Drug Metabolism Diabetic Cognitive Dysfunction: From Bench to Clinic
Current Medicinal Chemistry Gender Differences in Non-Obstructive Coronary Artery Disease
Current Pharmaceutical Design Endothelial Dysfunction, Impaired Endogenous Platelet Inhibition and Platelet Activation in Diabetes and Atherosclerosis
Current Vascular Pharmacology Association of Low BMI with Aortic Stiffness in Young Healthy Individuals
Current Hypertension Reviews A hypothesis for the role of RECK in angiogenesis
Current Vascular Pharmacology